| Literature DB >> 32257145 |
Isaac Iyinoluwa Olufadewa1,2,3, Miracle Ayomikun Adesina1,2, Toluwase Ayorinde1,2.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 32257145 PMCID: PMC7101491 DOI: 10.7189/jogh.10.010321
Source DB: PubMed Journal: J Glob Health ISSN: 2047-2978 Impact factor: 4.413
Gross domestic expenditure on R&D (GERD) as a percentage of GDP, 2017 or latest available year for sub-Saharan Africa*
| Country | Region | GERD |
|---|---|---|
| Nigeria | West Africa | 0.22% |
| Ghana | West Africa | 0.38% |
| Burkina Faso | West Africa | 0.67% |
| Mali | West Africa | 0.29% |
| Gabon | Central Africa | 0.58% |
| Democratic Republic of the Congo | Central Africa | 0.41% |
| Uganda | East Africa | 0.17% |
| Kenya | East Africa | 0.79% |
| Tanzania | East Africa | 0.53% |
| Zambia | East Africa | 0.29% |
| Mozambique | Southern Africa | 0.34% |
| Namibia | Southern Africa | 0.34% |
| Botswana | Southern Africa | 0.54% |
| South Africa | Southern Africa | 0.82% |
| Lesotho | Southern Africa | 0.05% |
| Madagascar | East Africa | 0.01% |
GDP – gross domestic product
*Source: World Bank data [3].